glp-1 muscle mass loss Weight with medicines does not result in a disproportionate loss of or function in obese mice and humans Muscle Loss With and Without

Investigating Liver Detoxification and Methylation A targeted history and laboratory assessment may help distinguish excessive exposure from impaired methylation, elevated SAH, poor transsulfuration, low glutathione, biliary dysfunction or gut-derived toxic burden

~12-15 hours (endogenous circulating) ~1-2 hours (plasma) ~1-2 hours (estimated) ~1 hour (58-64 minutes) Variable (multi-compound blend) ~3+ hours (estimated, plasma) Unknown (topical peptide: no systemic PK data) Unknown (topical peptide: no systemic PK data available) Unknown (oral peptide complex, no published PK data) Unknown (oral peptide complex) Unknown (topical peptide: no systemic PK data available) Unknown (topical peptide: no systemic PK data available) No systemic PK data available (topical cosmeceutical) Not measurable systemically: acts locally in the intestinal lumen and is degraded within the GI tract Not measurable (minimal systemic absorption) ~15-30 seconds (rapid degradation by kininases) 25 minutes (normal renal function)

Plug in the defaults to see what each dose delivers: Skincare (2.5 mL water with GHK-Cu anchor) Payload: GHK-Cu 2 mg BPC-157 0.4 mg TB-4 0.4 mg

Description BPC-157, an abbreviation for Body Protection Compound-157, derives from body protection compound (BPC), a protein naturally occurring in the human digestive tract

Purchasing from unauthorized online sources introduces product integrity and liability risks for clinical and home-use buyers

Case study: Relief from peripheral neuropathy with chiropractic care